首页> 外文会议>IEEE Annual Conference on Decision and Control >Implications of measurement assay type in design of HIV experiments
【24h】

Implications of measurement assay type in design of HIV experiments

机译:测量方法类型在HIV实验设计中的意义

获取原文

摘要

Time series measurements of circular viral epi-some (2-LTR) concentrations enable indirect quantification of persistent low-level Human Immunodeficiency Virus (HIV) replication in patients on Integrase-Inhibitor intensified Combined Antiretroviral Therapy (cART). In order to determine the magnitude of these low level infection events, blood has to be drawn from a patients at a frequency and volume that is strictly regulated by the Institutional Review Board (IRB). Once the blood is drawn, the 2-LTR concentration is determined by quantifying the amount of HIV DNA present in the sample via a PCR (Polymerase Chain Reaction) assay. Real time quantitative Polymerase Chain Reaction (qPCR) is a widely used method of performing PCR; however, a newer droplet digital Polymerase Chain Reaction (ddPCR) method has been shown to provide more accurate quantification of DNA. Using a validated model of HIV viral replication, this paper demonstrates the importance of considering DNA quantification assay type when optimizing experiment design conditions. Experiments are optimized using a Genetic Algorithm (GA) to locate a family of suboptimal sample schedules which yield the highest fitness. Fitness is defined as the expected information gained in the experiment, measured by the Kullback-Leibler Divergence (KLD) between the prior and posterior distributions of the model parameters. We compare the information content of the optimized schedules to uniform schedules as well as two clinical schedules implemented by researchers at UCSF and the University of Melbourne. This work shows that there is a significantly greater gain information in experiments using a ddPCR assay vs. a qPCR assay and that certain experiment design considerations should be taken when using either assay.
机译:循环病毒附加体(2-LTR)浓度的时间序列测量可对采用整合酶抑制剂强化联合抗逆转录病毒疗法(cART)的患者中的持久性低水平人类免疫缺陷病毒(HIV)复制进行间接定量。为了确定这些低水平感染事件的严重性,必须从患者中抽取血液,其频率和体积必须由机构审查委员会(IRB)严格监管。一旦抽血,就可以通过PCR(聚合酶链反应)测定法定量样品中存在的HIV DNA的量,从而确定2-LTR的浓度。实时定量聚合酶链反应(qPCR)是一种广泛使用的进行PCR的方法。然而,一种新型的液滴数字聚合酶链反应(ddPCR)方法已被证明可以更准确地定量DNA。使用经过验证的HIV病毒复制模型,本文证明了在优化实验设计条件时考虑DNA定量检测类型的重要性。使用遗传算法(GA)对实验进行了优化,以找到可产生最高适应性的次优样品计划。适应度定义为在实验中获得的预期信息,通过模型参数的先验分布和后验分布之间的Kullback-Leibler散度(KLD)进行测量。我们将优化计划的信息内容与统一计划以及由UCSF和墨尔本大学的研究人员实施的两个临床计划进行比较。这项工作表明,在使用ddPCR测定法进行的实验中,相对于在qPCR测定法中获得的收益信息要大得多,并且在使用任何一种测定法时都应考虑某些实验设计考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号